Anna Hernández-Aguilera Selected Research

Anna Hernández-Aguilera Research Topics

Disease

13	Inflammation (Inflammations) 12/2021 - 01/2013
7	Non-alcoholic Fatty Liver Disease 07/2022 - 06/2015
7	Neoplasms (Cancer) 01/2020 - 02/2013
6	Fatty Liver 07/2022 - 04/2016
5	Morbid Obesity 12/2023 - 01/2020
5	Obesity 07/2022 - 06/2015
4	Weight Loss (Weight Reduction) 12/2023 - 10/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 09/2015
4	Infections 10/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 12/2018 - 01/2017
2	Liver Diseases (Liver Disease) 12/2023 - 01/2021
2	Sepsis (Septicemia) 10/2022 - 11/2018
2	COVID-19 11/2021 - 06/2021
2	Communicable Diseases (Infectious Diseases) 08/2021 - 11/2018
2	Alcoholic Fatty Liver 05/2021 - 06/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 06/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 07/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 11/2018
2	Hyperlipidemias (Hyperlipidemia) 05/2019 - 05/2016
2	Peripheral Arterial Disease 05/2017 - 05/2015
2	Vascular Diseases (Vascular Disease) 05/2017 - 05/2015
2	Atherosclerosis 05/2015 - 05/2013
1	Overweight 12/2023
1	Catheter-Related Infections 10/2022
1	Chronic Renal Insufficiency 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 10/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Critical Illness (Critically Ill) 08/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 07/2019
1	Asthenia 12/2018
1	Dermatitis 12/2018
1	Renal Insufficiency (Renal Failure) 11/2018
1	Septic Shock (Toxic Shock Syndrome) 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Intermittent Claudication 10/2018
1	Chronic Limb-Threatening Ischemia 10/2018
1	Diabetes Mellitus 07/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

11	Aryldialkylphosphatase (Paraoxonase)IBA 02/2021 - 01/2017
5	AntioxidantsIBA 07/2019 - 05/2015
4	LipidsIBA 12/2023 - 05/2015
4	Galectin 3 (LGALS3)IBA 10/2022 - 05/2017
4	EnzymesIBA 07/2022 - 05/2015
4	ChemokinesIBA 01/2021 - 01/2013
4	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2015
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 05/2017
4	CC ChemokinesIBA 01/2020 - 01/2013
3	LigandsIBA 01/2021 - 01/2013
2	Adenosine Monophosphate (AMP)IBA 07/2022 - 05/2021
2	Protein Kinases (Protein Kinase)IBA 07/2022 - 05/2021
2	TOR Serine-Threonine KinasesIBA 07/2022 - 05/2021
2	Trace Elements (Biometals)IBA 12/2018 - 07/2018
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 06/2015
2	Triglycerides (Triacylglycerol)IBA 10/2017 - 06/2015
2	Metformin (Glucophage)FDA LinkGeneric 10/2017 - 04/2016
2	Chemokine ReceptorsIBA 05/2013 - 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	OxylipinsIBA 12/2023
1	AdipokinesIBA 12/2023
1	CreatinineIBA 10/2022
1	MetalsIBA 12/2021
1	IronIBA 12/2021
1	Transferrin (beta 2 Transferrin)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	AntibodiesIBA 11/2021
1	anti-IgGIBA 11/2021
1	ProcalcitoninIBA 08/2021
1	Mitogen-Activated Protein KinasesIBA 05/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Histones (Histone)IBA 12/2019
1	oxidized low density lipoproteinIBA 05/2019
1	SphingomyelinsIBA 05/2019
1	ChylomicronsIBA 05/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	Ki-67 Antigen (Ki 67 Antigen)IBA 12/2018
1	ElementsIBA 11/2018
1	HDL CholesterolIBA 11/2018
1	Versicans (Versican)IBA 10/2018
1	Collagen Type IV (Type IV Collagen)IBA 10/2018
1	MineralsIBA 07/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Serine (L-Serine)FDA Link 01/2018

Therapy/Procedure

6	Gastrectomy 12/2023 - 06/2015
4	Radiotherapy 01/2020 - 01/2017
3	Bariatric Surgery 05/2021 - 06/2015
2	Urinary Catheters 10/2022 - 01/2018
1	Catheters 10/2022
1	Operative Surgical Procedures 02/2021
1	Chemoradiotherapy 01/2021
1	Continuous Renal Replacement Therapy 11/2018